Retraction Note: Belinostat and panobinostat (HDACI): in vitro and in vivo studies in thyroid cancer

Daniel Chan¹, Yun Zheng^{2

3}, Jeffrey W Tyner⁴, Wee Joo Chng^{1

5}, Wen Wen Chien⁵, Sigal Gery², Geraldine Leong⁵, Glenn D Braunstein², H Phillip Koeffler^{6

7

8}

Affiliations

¹ National University Hospital, National University Cancer, Institute Singapore, 1E Kent Ridge Road, Singapore, 119228, Singapore.
² Division of Hematology/Oncology, Cedars-Sinai Medical Center, University of California at Los Angeles School of Medicine, 8700 Beverly Boulevard, Los Angeles, CA, 90048, USA.
³ State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-Sen University, 651 Dongfeng East Rd, Guangzhou, 510060, People's Republic of China.
⁴ Oregon Health and Science University, 3181 S.W. Sam Jackson, Park Rd., Portland, OR, 97239-3098, USA.
⁵ Cancer Science Institute Singapore, Centre for Translational Medicine, NUS, 14 Medical Drive, MD6, #12-01, Singapore, 117599, Singapore.
⁶ National University Hospital, National University Cancer, Institute Singapore, 1E Kent Ridge Road, Singapore, 119228, Singapore. mdchpk@nus.edu.sg.
⁷ Division of Hematology/Oncology, Cedars-Sinai Medical Center, University of California at Los Angeles School of Medicine, 8700 Beverly Boulevard, Los Angeles, CA, 90048, USA. mdchpk@nus.edu.sg.
⁸ Cancer Science Institute Singapore, Centre for Translational Medicine, NUS, 14 Medical Drive, MD6, #12-01, Singapore, 117599, Singapore. mdchpk@nus.edu.sg.

Daniel Chan et al. J Cancer Res Clin Oncol. 2025.

. 2025 Oct 21;151(12):299.

doi: 10.1007/s00432-025-06359-8.

Daniel Chan¹, Yun Zheng^{2

3}, Jeffrey W Tyner⁴, Wee Joo Chng^{1

5}, Wen Wen Chien⁵, Sigal Gery², Geraldine Leong⁵, Glenn D Braunstein², H Phillip Koeffler^{6

7

8}

¹ National University Hospital, National University Cancer, Institute Singapore, 1E Kent Ridge Road, Singapore, 119228, Singapore.
² Division of Hematology/Oncology, Cedars-Sinai Medical Center, University of California at Los Angeles School of Medicine, 8700 Beverly Boulevard, Los Angeles, CA, 90048, USA.
³ State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-Sen University, 651 Dongfeng East Rd, Guangzhou, 510060, People's Republic of China.
⁴ Oregon Health and Science University, 3181 S.W. Sam Jackson, Park Rd., Portland, OR, 97239-3098, USA.
⁵ Cancer Science Institute Singapore, Centre for Translational Medicine, NUS, 14 Medical Drive, MD6, #12-01, Singapore, 117599, Singapore.
⁶ National University Hospital, National University Cancer, Institute Singapore, 1E Kent Ridge Road, Singapore, 119228, Singapore. mdchpk@nus.edu.sg.
⁷ Division of Hematology/Oncology, Cedars-Sinai Medical Center, University of California at Los Angeles School of Medicine, 8700 Beverly Boulevard, Los Angeles, CA, 90048, USA. mdchpk@nus.edu.sg.
⁸ Cancer Science Institute Singapore, Centre for Translational Medicine, NUS, 14 Medical Drive, MD6, #12-01, Singapore, 117599, Singapore. mdchpk@nus.edu.sg.

No abstract available

Retraction of

Belinostat and panobinostat (HDACI): in vitro and in vivo studies in thyroid cancer.
Chan D, Zheng Y, Tyner JW, Chng WJ, Chien WW, Gery S, Leong G, Braunstein GD, Koeffler HP. Chan D, et al. J Cancer Res Clin Oncol. 2013 Sep;139(9):1507-14. doi: 10.1007/s00432-013-1465-6. Epub 2013 Jul 4. J Cancer Res Clin Oncol. 2013. Retraction in: J Cancer Res Clin Oncol. 2025 Oct 21;151(12):299. doi: 10.1007/s00432-025-06359-8. PMID: 23824064 Free PMC article. Retracted.